Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)
Germany
· Delayed Price · Currency is EUR 52.64
-2.74 (-4.95%)
At close: Dec 5, 2025
Arrowhead Pharmaceuticals Revenue
In the fiscal year ending September 30, 2025, Arrowhead Pharmaceuticals had annual revenue of $829.45M USD with 23,258.15% growth. Arrowhead Pharmaceuticals had revenue of $256.47M in the quarter ending September 30, 2025.
Revenue
$829.45M
Revenue Growth
+23,258.15%
P/S Ratio
10.15
Revenue / Employee
$1.17M
Employees
711
Market Cap
7.17B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 829.45M | 825.90M | 23,258.15% |
| Sep 30, 2024 | 3.55M | -237.18M | -98.52% |
| Sep 30, 2023 | 240.74M | -2.50M | -1.03% |
| Sep 30, 2022 | 243.23M | 104.94M | 75.89% |
| Sep 30, 2021 | 138.29M | 50.30M | 57.16% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |